Leucine enkephalin

Drug Profile

Leucine enkephalin

Alternative Names: METDoloron; Nanoenabled leucine5 enkephalin; NM 0127; NM 127

Latest Information Update: 24 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nanomerics
  • Developer Nanomerics; University of Exeter
  • Class Enkephalins; Essential amino acids; Opioid analgesics; Opioid peptides
  • Mechanism of Action Opioid delta receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Neuropathic pain

Most Recent Events

  • 19 Apr 2017 Chemical structure information added
  • 26 Dec 2016 Nanomerics plans clinical development for Neuropathic pain in 2017 (Nanomerics website, December 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top